A drug developed by Sanofi raised platelet counts and reduced bleeding episodes in patients with a rare autoimmune disorder ...

True to form, Vertex is following on with multiple other ... the stock made the top ten list of shorted large-cap stocks. A standard P/E valuation of the stock is stretched because the company ...

Wondering what all the fuss is about Gemini, Google's next-gen generative AI model family? Here's a handy roundup to get you ...

Thank you for attending today's SentinelOne Q3 fiscal year 2025 earnings conference call. My name is Jaimie, and I'll be your ...

Please refer to the documents we file from time to time with the SEC, in particular, our annual report on Form 10-K and our ...

What draws some of the world’s top sci-fi authors to the “Dao De Jing”?

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced longer-term data for CASGEVY™ (exagamglogene autotemcel) from global clinical trial ...

The Centers for Medicare & Medicaid Services said on Wednesday it had entered into agreements with Vertex Pharmaceuticals and ...

Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through ...

The company also said that Imagen 3, Google’s highest-quality text-to-image AI model, will be available to all Google Cloud customers globally on Vertex. Vertex AI is a managed platform that ...

As a result, biotech stocks can be highly volatile. Here's why I think Vertex Pharmaceuticals (NASDAQ: VRTX) is the ultimate biotech stock to buy with $500 right now. Jefferies has upgraded Vertex ...